Neuraminidase (NA)

Neuraminidase (NA)

Neuraminidase (NA) 분자 정보

Molecule Name
Neuraminidase
분자 별명
NA,Neuraminidase
Drug Development Progress
임상 약물 수5
시판 약물 수4
최고 연구 개발 단계Approved
표적 별명
Neuraminidase
분자 배경
Influenza, commonly known as 'the flu', is an infectious disease of birds and mammals caused by RNA viruses of the family Orthomyxoviridae, the influenza viruses. The virus is divided into three main types (Influenzavirus A, Influenzavirus B, and Influenzavirus C), which are distinguished by differences in two major internal proteins (hemagglutinin (HA) and neuraminidase (NA), which are the most important targets for the immune system. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle which makes it a great target for vaccine studies.

Neuraminidase (NA) 제품 목록

Species
  • Influenza A virus (A/Croatia/10136RV/2023) & (A/District of Columbia/27/2023)(1)
  • Influenza A virus (A/Victoria/4897/2022)(1)
  • Influenza A virus (Missouri/11/2025)(1)
  • Influenza A virus (Sydney/1359/2024)& (Singapore/GP20238/2024)(1)
Tag
  • His Tag(3)
  • His Tag & Avi Tag(1)
Host
  • HEK293(4)
Conjugate
  • Unconjugated(3)
  • Biotin-labeled(1)
Grade
  • RUO(4)
Low Endotoxin
  • No(4)
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
Neuraminidase (NA)
Influenza A virus (Missouri/11/2025) NA (H1N1) Protein, His Tag
Influenza A virus (Missouri/11/2025)
HEK293
SDS-PAGE
ELISASPR

$350.00

100ug
Neuraminidase (NA)
Influenza A virus (Sydney/1359/2024)& (Singapore/GP20238/2024) NA (H3N2) Protein, His Tag
Influenza A virus (Sydney/1359/2024)& (Singapore/GP20238/2024)
HEK293
SDS-PAGE
SPR

$350.00

100ug
Neuraminidase (NA)
Influenza A virus (A/Croatia/10136RV/2023) & (A/District of Columbia/27/2023) NA(H3N2) Protein, His Tag
Influenza A virus (A/Croatia/10136RV/2023) & (A/District of Columbia/27/2023)
HEK293
SDS-PAGE

$360.00

100ug
Neuraminidase (NA)
Avitag
NEE-V82Q3
Biotinylated Influenza A virus (A/Victoria/4897/2022) NA (H1N1) Protein, Avitag™,His Tag
Influenza A virus (A/Victoria/4897/2022)
HEK293
SDS-PAGE

$380.00

25ug
You Have Viewed 1-4 Of 4 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

FAQ

What should be verified before selecting NA?

Confirm subtype, strain, tag or biotinylation, host, and the assay readout required.

Can any recombinant NA protein be used in an enzyme-activity assay?

Check the selected construct’s activity data and assay suitability. Binding validation alone does not establish neuraminidase enzymatic activity.

Which NA formats suit capture assays?

Consider the biotinylated His/AviTag construct for streptavidin capture; verify binding performance for the assay.

Can NA reagents support antibody studies?

The portfolio includes an anti-NA antibody and serology-related kit, in addition to recombinant NA proteins.

Why match the NA strain to the study?

The listed proteins are strain-defined; sequence and subtype differences can affect binding and assay recognition.

What non-protein NA reagents are available?

The portfolio also includes an anti-NA antibody and a mouse anti-influenza antibody titer kit.

Are biotinylated NA proteins available?

Yes. Options include biotinylated H1N1 NA with His and AviTag.

Which NA protein subtypes are available?

Available options include influenza A H1N1 and H3N2 neuraminidase proteins from named strains.
Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
CD388CD-388; JNJ-0953; CD388Phase 3 ClinicalCidara Therapeutics Inc
Influenza, Human
상세
Peramivir Inhalation Solution (Langtian Medical Tech)Phase 2 ClinicalLangtian Medical Technology (Wuhan) Co Ltd
Influenza A virus infections; Influenza B virus infection
상세
Peramivir Inhalation Solution (广州南鑫药业)Phase 2 ClinicalGuangzhou Nanxin Pharma Co Ltd
Arthralgia; Cough; Fatigue; Headache; Influenza A virus infections; Influenza B virus infection; Influenza, Human; Musculoskeletal Pain; Nasal Obstruction
상세
Oseltamivir/PimodivirPhase 1 ClinicalJohnson & Johnson
Influenza A virus infections
상세
Oseltamivir orally disintegrating tablets(Hefei Industrial Pharma)HY-100209Phase 1 ClinicalHefei Industrial Pharmaceutical Co Ltd
Influenza A virus infections; Influenza B virus infection
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Laninamivir Octanoate HydrateCS-8958; R-118958ApprovedDaiichi Sankyo Co LtdInavirJapanInfluenza B virus infection; Influenza A virus infections; Influenza, Humannull2010-09-10
Asthma; Influenza A virus infections; Influenza B virus infection; Influenza, Human
상세
ZanamivirGG-167; GR-121167; GR-121167X; 4-Guanidino-Neu5Ac2enApprovedGlaxosmithkline Plc依乐韦, RelenzaUnited StatesInfluenza, HumanGlaxosmithkline Plc1999-07-26
Arthralgia; Dengue; Diabetes Mellitus, Type 2; Influenza, Human; Orthomyxoviridae Infections
상세
Oseltamivir PhosphateRo-64-0796; RO-640796; GS-4104; EN-241104; RO-640796/002; GS-4104/002; GS-4104-002ApprovedF. Hoffmann-La Roche Ltd, Gilead Sciences IncTamiflu, Hanmi Flu, 达菲SwitzerlandInfluenza, HumanF. Hoffmann-La Roche Ltd1999-09-21
Influenza A virus infections; Influenza in Birds; Influenza, Human; Kidney Failure, Chronic; Obesity; Purpura, Thrombocytopenic, Idiopathic
상세
Peramivir HydrateBCX-1812; JNJ-2; S-021812; RWJ-270201ApprovedBiocryst Pharmaceuticals IncPeramiflu, Alpivab, 力纬, Rapiacta, Rapivab, Enpiflu PremixJapanInfluenza, Humannull2010-01-13
Cough; Fatigue; Fever; Headache; Influenza A virus infections; Influenza B virus infection; Influenza, Human; Myalgia; Nasal Obstruction; Pharyngitis
상세
Customer Reviews